Literature DB >> 8346863

Seasonal allergic rhinitis and antihistamine effects on children's learning.

E F Vuurman1, L M van Veggel, M M Uiterwijk, D Leutner, J F O'Hanlon.   

Abstract

Children suffering from seasonal allergic rhinitis and matched normals were instructed on the use of a didactic computer simulation in a realistic classroom situation. Groups of atopic children received different treatments before instruction; ie, sedating (diphenylhydramine HCl) or nonsedating (loratadine) antihistamines or placebo. All returned after 2 weeks for an examination measuring factual and conceptual knowledge and the application of a learned strategy. Examination results showed large and consistent impairing effects of the allergic reaction on prior learning. Both the placebo and diphenhydramine groups learned significantly less than normal controls. The loratadine group's learning performance was superior to either of the other atopic groups' but still inferior to the normals'. Our conclusions are that the allergic reaction reduces learning ability in children and that this effect is partially counteracted by treatment with loratadine and aggravated by diphenhydramine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8346863

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  50 in total

Review 1.  Epidemiology of allergic rhinitis.

Authors:  R Michael Sly
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

Review 2.  Economic outcomes for the treatment of allergic rhinitis.

Authors:  C M Kozma; M K Sadik; M L Watrous
Journal:  Pharmacoeconomics       Date:  1996-07       Impact factor: 4.981

Review 3.  New insights into the second generation antihistamines.

Authors:  G M Walsh; L Annunziato; N Frossard; K Knol; S Levander; J M Nicolas; M Taglialatela; M D Tharp; J P Tillement; H Timmerman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial.

Authors:  Joris C Verster; A Marit de Weert; Saskia I R Bijtjes; Mounir Aarab; Armand W A A van Oosterwijck; Erik J E Eijken; Marinus N Verbaten; Edmund R Volkerts
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

Review 5.  Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.

Authors:  Rami Jean Salib; Peter Hugo Howarth
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  Use of, satisfaction with, and willingness to switch prescription and over-the-counter treatments for chronic urticaria: an online survey.

Authors:  Donald E Stull; Sonia Gavriel
Journal:  Patient       Date:  2009-09-01       Impact factor: 3.883

7.  [Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 2: Practical aspects of application].

Authors:  L von Bernus; P Högger; O Pfaar; L Klimek
Journal:  HNO       Date:  2012-08       Impact factor: 1.284

8.  Allergic rhinitis quality of life in urban children with asthma.

Authors:  Robin S Everhart; Sheryl J Kopel; Cynthia A Esteban; Elizabeth L McQuaid; Robert Klein; Christine E McCue; Daphne Koinis-Mitchell
Journal:  Ann Allergy Asthma Immunol       Date:  2014-02-28       Impact factor: 6.347

Review 9.  Allergic rhinitis in children : diagnosis and management strategies.

Authors:  William E Berger
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 10.  Impact of sleep as a specific marker of quality of life in allergic rhinitis.

Authors:  Vanesa González-Núñez; Antonio Luís Valero; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.